Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3144 results

Sort By:

Multimodal Immune and Neuroendocrine Assessment in Drinkers

Study ID: NCT07220148
Start Date: 2026-04
End Date: 2031-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

234

Intervention / Treatment

Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm

Sponsor

Auburn University

Source: clinicaltrials.gov

Share:
Add to list

Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

Study ID: NCT05700448
Start Date: 2026-06
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

Sugemalimab

Placebo

Pegaspargase

Gemcitabine

Oxaliplatin

Sponsor

CStone Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Study ID: NCT06834204
Start Date: 2026-03-15
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

266

Intervention / Treatment

PC2: Primary Care Connect

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list

Patient Satisfaction and Cosmetic Outcomes in Adhesive Strip Versus Suture Repair for Simple Facial Lacerations

Study ID: NCT06550999
Start Date: 2026-08
End Date: 2028-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

62

Intervention / Treatment

Laceration repair with adhesive strips

Laceration repair with sutures

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

PH 2 Pemigatinib in SDH-deficient GIST

Study ID: NCT07434843
Start Date: 2026-06
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Pemigatinib

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Virtual Reality Exposure Therapy (VRET) in Psychomotor Disadaptation Syndrome

Study ID: NCT06884735
Start Date: 2026-04-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

exposure to virtual reality

Sponsor

North Franche-Comte Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder

Study ID: NCT04231708
Start Date: 2026-10
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Yohimbine + Hydrocortisone

Active rTMS

Placebo

Sham rTMS

Sponsor

Wayne State University

Source: clinicaltrials.gov

Share:
Add to list

Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes

Study ID: NCT07392125
Start Date: 2026-05-15
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

800

Intervention / Treatment

Cytisinicline

Placebo

Behavioral Support

Sponsor

Achieve Life Sciences

Source: clinicaltrials.gov

Share:
Add to list

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

Study ID: NCT07102940
Start Date: 2026-05-01
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Eftilagimod Alfa (Efti)

Docetaxel-cyclophosphamide (TC) intravenous (i.v)

Dose dense Adriamycin-cyclophosphamide (AC) i.v

Sponsor

George Washington University

Source: clinicaltrials.gov

Share:
Add to list

ETSF for Latinx Young Adults with Alcohol Use Disorder

Study ID: NCT06722690
Start Date: 2027-01
End Date: 2029-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

eTSF

Educational materials

Sponsor

Tulane University

Source: clinicaltrials.gov

Share:
Add to list